Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Current Medicinal Chemistry|April 17, 2024
Therapeutic Strategies to Improve the Treatment of Pleural MesotheliomaLuca Mirra, Giovanni Luca Beretta, Daniela Lisini, et al.
Biochemical Pharmacology|January 7, 2022
Caffeic acid phenethyl ester targets ubiquitin-specific protease 8 and synergizes with cisplatin in endometrioid ovarian carcinoma cellsDiego Colombo, Laura Gatti, Linda Sjöstrand, et al.
European Journal of Medicinal Chemistry|August 1, 2026
Targeting oxysterol-binding protein (OSBP) as a novel strategy to inhibit herpes simplex virus 2 (HSV-2) replication: First structure-activity relationship study of antiviral cholenamide derivativesAndrea Civra, Fatima Nigro, Domiziana Porporato, et al.
Frontiers in Cell and Developmental Biology|December 29, 2022
The deubiquitinase USP8 regulates ovarian cancer cell response to cisplatin by suppressing apoptosisCristina Corno, Padraig D'Arcy, Marina Bagnoli, et al.
International Journal of Biological Sciences|March 14, 2025
PSMC6 regulation of ovarian cancer cisplatin resistance unravels a new mode for proteasome targetingMatteo Costantino, Luca Mirra, Padraig D'arcy, et al.
Frontiers in Cell and Developmental Biology|August 1, 2022
Targeting of the Lipid Metabolism Impairs Resistance to BRAF Kinase Inhibitor in MelanomaElisabetta Vergani, Giovanni L Beretta, Mariachiara Aloisi, et al.
Cancer Drug Resistance (Alhambra, Calif.)|October 23, 2025
Molecular targeting of the deubiquitinase USP14 to circumvent cisplatin resistance in ovarian carcinoma and identification of novel inhibitorsCristina Corno, Debora Russo, Francesco Pignotti, et al.
International Journal of Biological Sciences|June 22, 2026
USP18 Impacts Cisplatin Resistance in Ovarian Cancer Cells by Modulating DNA RepairCristina Corno, Matteo Costantino, Pietro Pettinari, et al.
Pageof 2